Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 2 |
2012 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab.
Cancer Biol Ther. 2011 Apr 15;11(8):732-9. doi: 10.4161/cbt.11.8.14889. Epub 2011 Apr 15.
Cancer Biol Ther. 2011.
PMID: 21330783
Clinical Trial.
Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers.
Rohrberg KS, Olesen RK, Pfeiffer P, Ladekarl M, Pappot H, Christensen IJ, Høyer-Hansen G, Sørensen M, Skov BG, Buysschaert I, Carmeliet P, Lassen U.
Rohrberg KS, et al.
Acta Oncol. 2012 Feb;51(2):234-42. doi: 10.3109/0284186X.2011.619568. Epub 2011 Oct 21.
Acta Oncol. 2012.
PMID: 22017239
Clinical Trial.
Item in Clipboard
Markers of angiogenesis and epidermal growth factor receptor signalling in patients with pancreatic and gastroesophageal junction cancer.
Rohrberg KS, Skov BG, Lassen U, Christensen IJ, Høyer-Hansen G, Buysschaert I, Pappot H.
Rohrberg KS, et al.
Cancer Biomark. 2010;7(3):141-51. doi: 10.3233/CBM-2010-0157.
Cancer Biomark. 2010.
PMID: 21263190
Item in Clipboard
Cite
Cite